-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JcD9zsg+Gf2G9ceZrZbKXmkbrP9YSRAotmJ4myPobxaYGDDTY3PtMvsBqkrXwz/D XDmjKIGsRgdDuyO/NTamvw== 0001176256-08-000473.txt : 20080410 0001176256-08-000473.hdr.sgml : 20080410 20080410163347 ACCESSION NUMBER: 0001176256-08-000473 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080331 FILED AS OF DATE: 20080410 DATE AS OF CHANGE: 20080410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIOTECH PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001096481 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1618 STATION STREET CITY: VANCOUVER STATE: A1 ZIP: V6A 1B6 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Walker Jeffrey Paul CENTRAL INDEX KEY: 0001432061 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30334 FILM NUMBER: 08750318 BUSINESS ADDRESS: BUSINESS PHONE: 604-221-7676 MAIL ADDRESS: STREET 1: 1618 STATION STREET CITY: VANCOUVER STATE: A1 ZIP: V6A 1B6 3/A 1 primary_doc.xml PRIMARY DOCUMENT X0202 3/A 2008-03-31 2008-04-10 0 0001096481 ANGIOTECH PHARMACEUTICALS INC ANPI 0001432061 Walker Jeffrey Paul 1618 STATION STREET VANCOUVER A1 V6A 1B6 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Scientific Officer Common Stock 10000 D 7.75% Senior Subordinated Notes due Apr. 1/14 50000 D Common Shares 2000 I by Walker Family Trust Awards 12.82 2006-08-01 2011-07-09 Common Stock 25000 D Awards 8.9 2007-03-01 2012-02-04 Common Stock 175000 D The option is currently exercisable as to 10417 shares. The option became exercisable on 8/1/2006 and will continue to vest with respect to the remaining 14583 shares in equal installments on a monthly basis until 7/1/2010. The option is currently exercisable as to 47396 shares. The option became exercisable on 3/1/2007 and will continue to vest with respect to the remaining 127604 shares in equal installments on a monthly basis until 2/1/2011. All Conversion or Exercise Prices are in Canadian funds. /s/ Jeffrey Walker 2008-04-10 -----END PRIVACY-ENHANCED MESSAGE-----